Joost H. Rutten, MD, PhD

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Nijmegen, Netherlands

Disclosure information not submitted.

Presentation(s):

• SUN-676 - A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Metreleptin in Subjects with Partial Lipodystrophy: The METRE-PL Study

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT